Search by
Poster Number

1, 2, 3, 4,
5, 6, 7, 8,
9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73

Click on the Poster to View the Poster Page

All Posters

POSTER 1

Evaluation of Risk of Formation of Atrophic Acne Scars During Acne Treatment with Trifarotene 50μg/g Cream versus Vehicle Cream: Results...

POSTER 2

Efficacy and Safety of Trifarotene Cream 50µg/g for the Treatment of Acne-Induced Post-Inflammatory Hyperpigmentation in Subjects with...

POSTER 3

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex Julie C. Harper, MD;...

POSTER 4

Early and Sustained Effects of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Leon H. Kircik, MD; Edward (Ted)...

POSTER 5

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case...

POSTER 6

Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Truncal Acne Leon H. Kircik, MD; Julie C....

POSTER 7

The Efficacy and Safety of Clascoterone Cream 1% for the Treatment of Acne Vulgaris Are Not Dependent on Patient Age and Sex: Results of...

POSTER 8

Efficacy and Safety of Clascoterone Cream 1% in Patients with Acne with Skin of Color: 16-Week Interim Analysis Leon Kircik, Susan C....

POSTER 9

Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata (AA): 3-Year Results from the ALLEGRO-LT...

POSTER 10

Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months in Patients with Alopecia Areata (AA) from the ALLEGRO Clinical Trial...

POSTER 11

Timing of Initial Hair Regrowth and Clinical Trial-Defined Response following Ritlecitinib Treatment in Patients with Alopecia Areata...

POSTER 12

Change in Patient-Reported Hair Satisfaction During Deuruxolitinib Treatment of Severe Alopecia Areata: Pooled Data from the Phase 3...

POSTER 13

Improvement in Anxiety and Depression in Adult Patients with Severe Alopecia Areata Treated with Deuruxolitinib: Pooled Data from the...

POSTER 14

INTEGUMENT-INFANT: A Phase 2, 4-Week Open-Label Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less than 2 Years Old...

POSTER 15

Tapinarof Cream 1% Once Daily: Maintenance of Low Disease Activity Including Pruritus Through End of the Treatment-free Interval in a...

POSTER 16

Real-World Insights on Systemic Treatments and Disease Control in Atopic Dermatitis: Patient Satisfaction and Recap of Atopic Eczema...

POSTER 17

Patients Maintain Stable Response with No or Minimal Fluctuations during 3 Years of Continuous Treatment with Lebrikizumab during...

POSTER 18

Long-term Efficacy and Safety of Lebrikizumab Is Maintained in Patients with Moderate-to-Severe Atopic Dermatitis: Results Up to 3 Years...

POSTER 19

Lebrikizumab Improves Atopic Dermatitis in Patients with Limited Skin Involvement and High Itch Shawn Kwatra, Thomas Werfel, Martin...

POSTER 20

Nemolizumab Long-Term Safety and Efficacy up to 104 Weeks in the ARCADIA Open-Label Extension Study in Adolescents and Adults with...

POSTER 21

Long-Term Safety and Disease Control of Ruxolitinib Cream in Children Aged 2 to 6 and 7 to 11 Years With Atopic Dermatitis: Results From...

POSTER 22

Real-World Effectiveness of Tralokinumab in Adults with Atopic Dermatitis: Interim Data on Improvements in Patients with Head and Neck...

POSTER 23

Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab Matthias...

POSTER 24

Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for Up to 6...

Search by Poster Number

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73